1.
INHIBITIVE EFFECTS OF SANJIA YIGAN GRANULE ON HEPATIC FIBROSIS IN RATS
三甲益肝颗粒对大鼠肝纤维化的抑制作用
2.
The Efficacy and Mechanism Study of Yinlanyigan Granules Preventing and Treating Acute Drug-induced Disease
茵兰益肝颗粒治疗急性药物性肝损伤的疗效与机制探讨
3.
Inhibition of Sanjiayigan granule on expressions of procollagen typeⅠand Ⅲ mRNA in hepatic fibrosis rats
三甲益肝颗粒对肝纤维化大鼠Ⅰ型和Ⅲ型前胶原mRNA表达的抑制作用
4.
Effect of yangganyishui granule on blood pressure,ET-1 and NO in SHR
养肝益水颗粒对SHR大鼠血压及ET-1、NO的影响
5.
The Experimental and Theoretical Study on Alcoholic Fatty Liver by Yiqibugankeli (YQBG) Granule;
益气补肝颗粒治疗酒精性脂肪肝的实验研究和理论探讨
6.
The Clinical Effects and Significance of Serum sFas/sFasL Study on Treatment of Lupus Nephritis by Yi Shen Granule;
益肾颗粒剂对肝肾阴虚型狼疮肾炎患者血清sFas/sFasL水平的影响
7.
Clinical Study on Treatment of Chronic Hepatitis B by "YiQiHuoXue" (YQHX) Particles
益气活血颗粒治疗慢性乙型肝炎气虚血瘀证的临床研究
8.
Effect of Yangganyishui Granule on Blood Pressure,Urine MA and β_2-MG in Spontaneous Hypertension Rats
养肝益水颗粒对自发性高血压大鼠血压及尿MA、β_2-MG的影响
9.
Effects of Yanggan Yishui Granules on the Serum Levels of Nitric Oxide and High Sensitive C-reactive Protein in Essential Hypertension Patients with Early Renal Damage
养肝益水颗粒对原发性高血压早期肾损害患者血清NO、hs-CRP的影响
10.
Determination of leonurine in leonurus granule and extractum by UPLC
UPLC测定益母草颗粒和益母草膏中益母草碱含量
11.
Study on Toxicity of Liver Cells Induced by Iron Oxide Nanoparticles;
Fe_3O_4纳米颗粒的肝细胞毒性研究
12.
Determination of Scutellarin in Ruanganshengbai Granules by HPLC
HPLC测定软肝升白颗粒中黄芩苷的含量
13.
Determination of Berberine Hydrochloride in Qinggan Granules by HPLC
HPLC法测定清肝颗粒中小檗碱的含量
14.
Principal Pharmacodynamics of Baogangning Granule in Hepatic Fibrosis;
保肝宁颗粒剂抗肝纤维化的主要药效学研究
15.
The Influence of Oxidative Injury to the Rats in Cirrhosis of Liver with Rou Gan Xiao Zheng Granule;
柔肝消癥颗粒对肝硬化大鼠氧化损伤的影响
16.
Experimental Study on Treating Chronic Hepatitis B With Shenqi Yiganling Pallet;
参杞苡甘苓颗粒抗乙肝病毒、抗肝损伤实验研究
17.
Effect of Shugan Granules on Perosisome Proliferator-activated Receptor Gamma mRNA in Non-alcoholic Fatty Liver Disease in Rats
舒肝颗粒对非酒精性脂肪性肝病PPAR-γmRNA的影响
18.
PHARMACODYNAMIC STUDY ON ANTI-EXPERIMENTAL HEPATIC FIBROSIS OF GANXIAN KELI
肝纤颗粒抗实验性肝纤维化药效学研究